SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-015265
Filing Date
2018-08-13
Accepted
2018-08-13 07:01:41
Documents
47
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20180630_10q.htm 10-Q 498344
2 EXHIBIT 31.1 ex_120939.htm EX-31.1 12264
3 EXHIBIT 31.2 ex_120941.htm EX-31.2 12302
4 EXHIBIT 32.1 ex_120942.htm EX-32.1 4614
5 EXHIBIT 32.2 ex_120943.htm EX-32.2 4891
  Complete submission text file 0001437749-18-015265.txt   2844634

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snbp-20180630.xml EX-101.INS 453799
7 XBRL TAXONOMY EXTENSION SCHEMA snbp-20180630.xsd EX-101.SCH 36218
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snbp-20180630_cal.xml EX-101.CAL 26694
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snbp-20180630_def.xml EX-101.DEF 250946
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snbp-20180630_lab.xml EX-101.LAB 218087
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snbp-20180630_pre.xml EX-101.PRE 265953
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55242 | Film No.: 181010241
SIC: 2834 Pharmaceutical Preparations